vs
Side-by-side financial comparison of Community Healthcare Trust Inc (CHCT) and RHYTHM PHARMACEUTICALS, INC. (RYTM). Click either name above to swap in a different company.
RHYTHM PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($57.3M vs $30.9M, roughly 1.9× Community Healthcare Trust Inc). Community Healthcare Trust Inc runs the higher net margin — 46.6% vs -83.0%, a 129.6% gap on every dollar of revenue. On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (36.9% vs 5.6%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (48.5% CAGR vs 2.7%).
Medical Properties Trust, Inc. (MPT) is an international real estate investment trust (REIT) based in Birmingham, Alabama that purchases and invests in healthcare facilities and for-profit healthcare holding companies, primarily in the United States and Europe. Their property acquisitions often come in the form of sale-leaseback agreements, in which the original property owner sells the property to MPT and becomes their tenant. MPT's tenants are generally subject to long-term triple net lease...
Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.
CHCT vs RYTM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $30.9M | $57.3M |
| Net Profit | $14.4M | $-47.5M |
| Gross Margin | — | 91.6% |
| Operating Margin | — | -82.2% |
| Net Margin | 46.6% | -83.0% |
| Revenue YoY | 5.6% | 36.9% |
| Net Profit YoY | 687.6% | -9.6% |
| EPS (diluted) | $0.52 | $-0.73 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $30.9M | $57.3M | ||
| Q3 25 | $31.1M | $51.3M | ||
| Q2 25 | $29.1M | $48.5M | ||
| Q1 25 | $30.1M | $32.7M | ||
| Q4 24 | $29.3M | $41.8M | ||
| Q3 24 | $29.6M | $33.3M | ||
| Q2 24 | $27.5M | $29.1M | ||
| Q1 24 | $29.3M | $26.0M |
| Q4 25 | $14.4M | $-47.5M | ||
| Q3 25 | $1.6M | $-52.9M | ||
| Q2 25 | $-12.6M | $-46.6M | ||
| Q1 25 | $1.6M | $-49.5M | ||
| Q4 24 | $1.8M | $-43.3M | ||
| Q3 24 | $1.7M | $-43.6M | ||
| Q2 24 | $-10.4M | $-32.3M | ||
| Q1 24 | $3.7M | $-141.4M |
| Q4 25 | — | 91.6% | ||
| Q3 25 | — | 89.3% | ||
| Q2 25 | — | 88.6% | ||
| Q1 25 | — | 88.8% | ||
| Q4 24 | — | 90.9% | ||
| Q3 24 | — | 88.5% | ||
| Q2 24 | — | 89.9% | ||
| Q1 24 | — | 89.2% |
| Q4 25 | — | -82.2% | ||
| Q3 25 | — | -102.6% | ||
| Q2 25 | — | -93.4% | ||
| Q1 25 | — | -143.7% | ||
| Q4 24 | — | -98.6% | ||
| Q3 24 | — | -132.0% | ||
| Q2 24 | — | -139.2% | ||
| Q1 24 | — | -538.7% |
| Q4 25 | 46.6% | -83.0% | ||
| Q3 25 | 5.3% | -103.1% | ||
| Q2 25 | -43.2% | -96.1% | ||
| Q1 25 | 5.3% | -151.4% | ||
| Q4 24 | 6.3% | -103.6% | ||
| Q3 24 | 5.9% | -131.2% | ||
| Q2 24 | -37.9% | -110.9% | ||
| Q1 24 | 12.5% | -544.4% |
| Q4 25 | $0.52 | $-0.73 | ||
| Q3 25 | $0.03 | $-0.82 | ||
| Q2 25 | $-0.50 | $-0.75 | ||
| Q1 25 | $0.03 | $-0.81 | ||
| Q4 24 | $0.04 | $-0.71 | ||
| Q3 24 | $0.04 | $-0.73 | ||
| Q2 24 | $-0.42 | $-0.55 | ||
| Q1 24 | $0.11 | $-2.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.3M | $388.9M |
| Total DebtLower is stronger | $532.2M | — |
| Stockholders' EquityBook value | $429.4M | $139.1M |
| Total Assets | $990.8M | $480.2M |
| Debt / EquityLower = less leverage | 1.24× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.3M | $388.9M | ||
| Q3 25 | $3.4M | $416.1M | ||
| Q2 25 | $4.9M | $291.0M | ||
| Q1 25 | $2.3M | $314.5M | ||
| Q4 24 | $4.4M | $320.6M | ||
| Q3 24 | $2.8M | $298.4M | ||
| Q2 24 | $734.0K | $319.1M | ||
| Q1 24 | $3.8M | $201.2M |
| Q4 25 | $532.2M | — | ||
| Q3 25 | $530.1M | — | ||
| Q2 25 | $500.1M | — | ||
| Q1 25 | $496.0M | — | ||
| Q4 24 | $486.0M | — | ||
| Q3 24 | $473.7M | — | ||
| Q2 24 | $457.6M | — | ||
| Q1 24 | $442.3M | — |
| Q4 25 | $429.4M | $139.1M | ||
| Q3 25 | $426.8M | $148.8M | ||
| Q2 25 | $437.8M | $-11.9M | ||
| Q1 25 | $461.3M | $18.9M | ||
| Q4 24 | $476.0M | $21.7M | ||
| Q3 24 | $477.2M | $11.2M | ||
| Q2 24 | $497.8M | $39.3M | ||
| Q1 24 | $511.6M | $61.6M |
| Q4 25 | $990.8M | $480.2M | ||
| Q3 25 | $987.3M | $506.9M | ||
| Q2 25 | $966.3M | $372.7M | ||
| Q1 25 | $985.1M | $386.7M | ||
| Q4 24 | $992.6M | $392.3M | ||
| Q3 24 | $981.8M | $363.6M | ||
| Q2 24 | $983.2M | $381.8M | ||
| Q1 24 | $982.7M | $258.7M |
| Q4 25 | 1.24× | — | ||
| Q3 25 | 1.24× | — | ||
| Q2 25 | 1.14× | — | ||
| Q1 25 | 1.08× | — | ||
| Q4 24 | 1.02× | — | ||
| Q3 24 | 0.99× | — | ||
| Q2 24 | 0.92× | — | ||
| Q1 24 | 0.86× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $56.4M | $-25.4M |
| Free Cash FlowOCF − Capex | $35.9M | — |
| FCF MarginFCF / Revenue | 116.0% | — |
| Capex IntensityCapex / Revenue | 66.3% | — |
| Cash ConversionOCF / Net Profit | 3.91× | — |
| TTM Free Cash FlowTrailing 4 quarters | $62.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $56.4M | $-25.4M | ||
| Q3 25 | $12.7M | $-26.6M | ||
| Q2 25 | $13.8M | $-23.3M | ||
| Q1 25 | $14.4M | $-40.4M | ||
| Q4 24 | $58.9M | $-18.8M | ||
| Q3 24 | $13.8M | $-25.2M | ||
| Q2 24 | $16.7M | $-29.1M | ||
| Q1 24 | $12.6M | $-40.7M |
| Q4 25 | $35.9M | — | ||
| Q3 25 | $7.6M | — | ||
| Q2 25 | $9.6M | — | ||
| Q1 25 | $9.7M | — | ||
| Q4 24 | $34.2M | — | ||
| Q3 24 | $6.7M | — | ||
| Q2 24 | $9.5M | — | ||
| Q1 24 | $7.5M | — |
| Q4 25 | 116.0% | — | ||
| Q3 25 | 24.6% | — | ||
| Q2 25 | 32.9% | — | ||
| Q1 25 | 32.3% | — | ||
| Q4 24 | 116.9% | — | ||
| Q3 24 | 22.5% | — | ||
| Q2 24 | 34.7% | — | ||
| Q1 24 | 25.7% | — |
| Q4 25 | 66.3% | — | ||
| Q3 25 | 16.3% | — | ||
| Q2 25 | 14.5% | — | ||
| Q1 25 | 15.6% | — | ||
| Q4 24 | 84.1% | — | ||
| Q3 24 | 24.2% | — | ||
| Q2 24 | 26.1% | — | ||
| Q1 24 | 17.4% | — |
| Q4 25 | 3.91× | — | ||
| Q3 25 | 7.76× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 9.06× | — | ||
| Q4 24 | 32.14× | — | ||
| Q3 24 | 7.92× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 3.45× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
